For pharmaceutical manufacturers and R&D teams focused on antiviral therapies, securing a reliable supply of high-quality intermediates is paramount. Peramivir, a crucial drug for influenza treatment, requires specific, well-characterized building blocks for its synthesis. Among these, Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate (CAS: 168683-02-1) stands out as a key precursor. This article aims to guide procurement managers and research scientists in understanding what to look for when sourcing this vital compound.
Understanding the Importance of Peramivir Intermediates
Peramivir is a neuraminidase inhibitor that plays a significant role in combating influenza viruses. The efficacy and purity of the final Active Pharmaceutical Ingredient (API) are directly dependent on the quality of the intermediates used in its multi-step synthesis. This makes the selection of a dependable supplier for intermediates like Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate a critical decision. When looking to buy this intermediate, pharmaceutical buyers should prioritize manufacturers that demonstrate a strong commitment to quality control and product consistency.
Key Considerations for Sourcing CAS 168683-02-1
When evaluating potential suppliers, several factors should be taken into account:
The Role of Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate
This specific intermediate, characterized by its cyclopentene ring structure and functional groups, serves as a critical building block in the complex chemical synthesis of Peramivir. Its precise stereochemistry and functionalization are key to the successful assembly of the final antiviral molecule. Pharmaceutical companies looking to purchase this compound should confirm that the supplied material meets the exact specifications required for their patented synthesis routes.
In conclusion, when sourcing Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate, prioritize suppliers offering high purity, consistent quality, and a reliable supply chain. Companies like NINGBO INNO PHARMCHEM CO.,LTD. are well-positioned to meet these demands, offering valuable support to the global pharmaceutical industry in its fight against influenza.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.